James D. Brooks

Publication Details

  • Plasma selenium level before diagnosis and the risk of prostate cancer development.

    Brooks JD, Metter EJ, Chan DW, Sokoll LJ, Landis P, Nelson WG, Muller D, Andres R, Carter HB. J Urol. 2001; 166 (6): 2034-8

    Epidemiological studies and a randomized intervention trial suggest that the risk of prostate cancer may be reduced by selenium intake. We investigated whether plasma selenium level before diagnosis correlated with the risk of later developing prostate cancer.

    PubMedID: 11696701

Stanford Medicine Resources:

Footer Links: